Figure 7 | Scientific Reports

Figure 7

From: Identification of m6A suppressor EIF4A3 as a novel cancer prognostic and immunotherapy biomarker through bladder cancer clinical data validation and pan-cancer analysis

Figure 7

The correlation between EIF4A3 and and immune subtypes across various human cancers. (A) Analysis of its association in ACC; (B) analysis of its association in BLCA; (C) analysis of its association in BRCA; (D) analysis of its association in COAD; (E) analysis of its association in HNSC; (F) analysis of its association in KICH; (G) analysis of its association in KIRC; (H) analysis of its association in KIRP; (I) analysis of its association in LIHC; (J) analysis of its association in LUAD; (K) analysis of its association in LUSC; (L) analysis of its association in MESO; (M) analysis of its association in OV; (N) analysis of its association in PRAD; (O) analysis of its association in SARC; (P) analysis of its association in STAD; (Q) analysis of its association in UCEC.

Back to article page